Albany Molecular Research has entered into a research collaboration with Navigen Pharmaceuticals to develop new drug therapies.

Albany will provide fully integrated drug discovery services such as assay development, computer-aided drug discovery, in vitro ADMET, medicinal chemistry and screening under the multi-year collaboration.

Albany will aim to advance Navigen’s early drug discovery efforts.